MDPI and ACS Style
Bermejo-Guerrero, L.; de Fuenmayor-Fernández de la Hoz, C.P.; Guerrero-Molina, M.P.; Martín-Jiménez, P.; Blázquez, A.; Serrano-Lorenzo, P.; Lora, D.; Morales-Conejo, M.; González-Martínez, I.; López-Jiménez, E.A.;
et al. Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. J. Clin. Med. 2023, 12, 2435.
https://doi.org/10.3390/jcm12062435
AMA Style
Bermejo-Guerrero L, de Fuenmayor-Fernández de la Hoz CP, Guerrero-Molina MP, Martín-Jiménez P, Blázquez A, Serrano-Lorenzo P, Lora D, Morales-Conejo M, González-Martínez I, López-Jiménez EA,
et al. Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. Journal of Clinical Medicine. 2023; 12(6):2435.
https://doi.org/10.3390/jcm12062435
Chicago/Turabian Style
Bermejo-Guerrero, Laura, Carlos Pablo de Fuenmayor-Fernández de la Hoz, María Paz Guerrero-Molina, Paloma Martín-Jiménez, Alberto Blázquez, Pablo Serrano-Lorenzo, David Lora, Montserrat Morales-Conejo, Irene González-Martínez, Elena Ana López-Jiménez,
and et al. 2023. "Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome" Journal of Clinical Medicine 12, no. 6: 2435.
https://doi.org/10.3390/jcm12062435